Hype or hope? A review of challenges in balancing tumor control and treatment toxicity in breast cancer from the perspective of the radiation oncologist

• Javier González-Viguera ^[1] ; Evelyn Martínez-Pérez ^[1] ; Héctor Pérez-Montero ^[1] ; Marina Arangüena ^[1] ; Ferran Guedea ^[1] ; Cristina Gutiérrez-Miguélez ^[1]
  1. [1] Institute Catalá Oncología

     Institute Catalá Oncología

     Barcelona, España

     
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 26, Nº. 3, 2024, págs. 561-573
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • The aim of this article is to discuss the challenges and new strategies in managing breast cancer patients, with a specific focus on radiation oncology and the importance of balancing oncologic outcomes with quality of life and post-treatment morbidity. A comprehensive literature review was conducted to identify advances in the management of breast cancer, exploring de-escalation strategies, hypofractionation schemes, predictors and tools for reducing toxicity (radiation-induced lymphocyte apoptosis, deep inspiration breath-hold, adaptive radiotherapy), enhancer treatments (hyperthermia, immunotherapy) and innovative diagnostic modalities (PET-MRI, omics). Balancing oncologic outcomes with quality of life and post-treatment morbidity is crucial in the era of personalized medicine. Radiotherapy plays a critical role in the management of breast cancer patients. Large randomized trials are necessary to generalize some practices and cost remains the main obstacle for many innovations that are already applicable.